Next Article in Journal
Using Human ‘Personalized’ Cybrids to Identify Drugs/Agents That Can Regulate Chronic Lymphoblastic Leukemia Mitochondrial Dysfunction
Next Article in Special Issue
The Future of Precision Oncology
Previous Article in Journal
Are Therapies That Target α-Synuclein Effective at Halting Parkinson’s Disease Progression? A Systematic Review
Previous Article in Special Issue
Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study
 
 
Review

Article Versions Notes

Int. J. Mol. Sci. 2023, 24(13), 11023; https://doi.org/10.3390/ijms241311023
Action Date Notes Link
article xml file uploaded 3 July 2023 09:35 CEST Original file -
article xml uploaded. 3 July 2023 09:35 CEST Update https://www.mdpi.com/1422-0067/24/13/11023/xml
article pdf uploaded. 3 July 2023 09:35 CEST Version of Record https://www.mdpi.com/1422-0067/24/13/11023/pdf
article supplementary file uploaded. 3 July 2023 09:35 CEST - https://www.mdpi.com/1422-0067/24/13/11023#supplementary
article html file updated 3 July 2023 09:36 CEST Original file -
article html file updated 20 July 2023 20:12 CEST Update https://www.mdpi.com/1422-0067/24/13/11023/html
Back to TopTop